These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19157167)

  • 21. The serum pentraxin-3 is elevated in patients with cardiac syndrome X.
    Büyükkaya E; Karakaş MF; Kurt M; Motor S; Akçay AB; Büyükkaya S; Karakaş E; Sen N
    Turk Kardiyol Dern Ars; 2013 Jun; 41(4):290-5. PubMed ID: 23760115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of flow mediated dilation with inflammatory markers in patients with impaired cardiac function. Beneficial effects of inhibition of ACE.
    Kovacs I; Toth J; Tarjan J; Koller A
    Eur J Heart Fail; 2006 Aug; 8(5):451-9. PubMed ID: 16325470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of platelet reactivity, endothelial function, and inflammatory status on outcomes in patients with stable angina pectoris on clopidogrel therapy.
    Woo JS; Kim W; Jang HH; Kim JB; Kim WS; Kim KS
    Am J Cardiol; 2014 Mar; 113(5):786-92. PubMed ID: 24388620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brachial artery flow-mediated vasodilation in patients with cardiac syndrome X.
    Li AH; Lee BC; Chen KC; Weng CS; Chu SH
    Angiology; 2008; 59(5):581-6. PubMed ID: 18388101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial function in patients with chest pain and normal coronary angiograms.
    Grabczewska Z; Thews M; Góralczyk K; Kubica J
    Kardiol Pol; 2007 Oct; 65(10):1199-206; discussion 1207. PubMed ID: 17979048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The particular interactions of the traditional cardiovascular risk factors with different circulating specific leukocyte subtype counts in blood: an observational study.
    Kocaman SA; Sahinarslan A; Kunak T; Balcioğlu S; Cetin M; Cemri M; Timurkaynak T; Boyaci B; Cengel A
    Anadolu Kardiyol Derg; 2011 Nov; 11(7):573-81. PubMed ID: 21911321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of inflammation on adverse cardiovascular events in patients with acute coronary syndromes.
    Fiechter M; Ghadri JR; Jaguszewski M; Siddique A; Vogt S; Haller RB; Halioua R; Handzic A; Kaufmann PA; Corti R; Lüscher TF; Templin C
    J Cardiovasc Med (Hagerstown); 2013 Nov; 14(11):807-14. PubMed ID: 23572059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory and endothelial markers in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Alexandraki K; Piperi C; Protogerou A; Katsikis I; Paterakis T; Lekakis J; Panidis D
    Eur J Clin Invest; 2006 Oct; 36(10):691-7. PubMed ID: 16968464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired flow-mediated vasodilation in type 2 diabetes: lack of relation to microvascular dysfunction.
    Meyer MF; Lieps D; Schatz H; Pfohl M
    Microvasc Res; 2008 May; 76(1):61-5. PubMed ID: 18448131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial activation in patients with cardiac syndrome X.
    Desideri G; Gaspardone A; Gentile M; Santucci A; Gioffrè PA; Ferri C
    Circulation; 2000 Nov; 102(19):2359-64. PubMed ID: 11067789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of systemic microvascular dysfunction in syndrome X and in variant angina.
    Bøtker HE; Sonne HS; Sørensen KE
    Am J Cardiol; 1996 Jul; 78(2):182-6. PubMed ID: 8712140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between high-sensitivity C-reactive protein (hs-CRP) and white blood cell count (WBC) as an inflammatory component of metabolic syndrome in Japanese.
    Oda E; Kawai R
    Intern Med; 2010; 49(2):117-24. PubMed ID: 20075574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. White blood cell count is not associated with flow-mediated vasodilation or nitroglycerine-induced vasodilation.
    Kishimoto S; Maruhashi T; Kajikawa M; Harada T; Yamaji T; Han Y; Mizobuchi A; Hashimoto Y; Yoshimura K; Nakano Y; Chayama K; Goto C; Yusoff FM; Nakashima A; Higashi Y
    Sci Rep; 2022 May; 12(1):8201. PubMed ID: 35581258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between c-reactive protein and the asymmetric dimethylarginine-induced endothelial dysfunction pathway in vasospastic angina.
    Feng W; Sun L; Song Y; Qu XF
    Pharmazie; 2014 Mar; 69(3):234-7. PubMed ID: 24716416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism.
    Nishizaka MK; Zaman MA; Green SA; Renfroe KY; Calhoun DA
    Circulation; 2004 Jun; 109(23):2857-61. PubMed ID: 15173035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome.
    Brinkworth GD; Noakes M; Moran LJ; Norman R; Clifton PM
    BJOG; 2006 Nov; 113(11):1308-14. PubMed ID: 17059392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum levels of C-reactive protein and uric acid in patients with cardiac syndrome X.
    Eroglu S; Elif Sade L; Yildirir A; Demir O; Bozbas H; Muderrisoglu H
    Acta Cardiol; 2009 Apr; 64(2):207-11. PubMed ID: 19476113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of homocysteine levels on endothelial function and their relation with microvascular complications in T2DM patients without macrovascular disease.
    Karabag T; Kaya A; Temizhan A; Koç F; Yavuz S; Cam S
    Acta Diabetol; 2007 Jun; 44(2):69-75. PubMed ID: 17530470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease.
    Recio-Mayoral A; Rimoldi OE; Camici PG; Kaski JC
    JACC Cardiovasc Imaging; 2013 Jun; 6(6):660-7. PubMed ID: 23643286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
    Freestone B; Chong AY; Nuttall S; Lip GY
    Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.